Verastem Oncology to Present at Upcoming Investor Conferences

Core Insights - Verastem Oncology is focused on developing new medicines for patients with RAS/MAPK pathway-driven cancers [1] Conference Participation - The management team of Verastem Oncology is scheduled to present at the Guggenheim Healthcare Conference on November 11 at 1:00 pm ET [1] - Additionally, the company will participate in the Jefferies Global Healthcare Conference in London on November 19 at 2:30 pm [1]